Abstract
A series of imides and lactams derived from 4-amino-N-benzylpyroglutamyl-L-phenylalanine was prepared and evaluated for activity as VCAM/VLA-4 antagonists. Imides were more potent than the corresponding lactams; several had subnanomolar IC50s in an ELISA based assay and were also highly effective at blocking VLA-4 expressing Ramos cell binding to VCAM coated plates.
MeSH terms
-
Cell Adhesion / drug effects
-
Dipeptides / chemistry*
-
Dipeptides / pharmacology*
-
Enzyme-Linked Immunosorbent Assay
-
Humans
-
Imides / chemistry
-
Imides / pharmacology*
-
Inhibitory Concentration 50
-
Integrin alpha4beta1
-
Integrins / antagonists & inhibitors*
-
Lactams / chemistry
-
Lactams / pharmacology*
-
Molecular Structure
-
Phenylalanine / analogs & derivatives*
-
Pyrrolidonecarboxylic Acid / analogs & derivatives*
-
Receptors, Lymphocyte Homing / antagonists & inhibitors*
-
Tumor Cells, Cultured
Substances
-
Dipeptides
-
Imides
-
Integrin alpha4beta1
-
Integrins
-
Lactams
-
Receptors, Lymphocyte Homing
-
Phenylalanine
-
Pyrrolidonecarboxylic Acid